Abstract
OCCUPANCY of the T-cell antigen receptor is insufficient to induce T-cell activation optimally; a second co-stimulatory signal is required1. Exposure of T-cell clones to complexes of antigen with major histocompatibility complex molecules in the absence of the co-stimulatory signal induces a state of clonal anergy. This requirement for two stimuli for T-cell activation could have an important role in vivo in establishing peripheral tolerance to antigens not encountered in the thymus1,2. The receptor on T cells required for the co-stimulatory stimulus involved in the prevention of anergy has not been identified. The human T-cell antigen CD28 provides a signal that can synergize with T-cell antigen receptor stimulation in activating T cells to proliferate and secrete lymphokines3–6. Here we report that a monoclonal antibody against the murine homologue of CD28 (ref. 7; J.A.G. et al., manuscript in preparation) can provide a co-stimulatory signal to naive CD4+ T cells and to T-cell clones. Moreover, we demonstrate that this co-stimulatory signal can block the induction of anergy in T-cell clones.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
CAR-T cell potency: from structural elements to vector backbone components
Biomarker Research Open Access 19 September 2022
-
Changes of T lymphocyte subpopulations and their roles in predicting the risk of Parkinson’s disease
Journal of Neurology Open Access 24 May 2022
-
Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation
Cell & Bioscience Open Access 23 April 2022
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Mueller, D. L., Jenkins, M. K. & Schwartz, R. H. A. Rev. Immun. 7, 445–480 (1989).
Schwartz, R. H. Science 248, 1349–1356 (1990).
Hansen, J. A., Martin, P. J. & Nowinski, R. C. Immunogenetics 10, 247–260 (1980).
Martin, P. J. et al. J. Immun. 136, 3282–3287 (1986).
Weiss, A., Manager, B. & Imboden, J. J. Immun. 137, 819–825 (1986).
June, C. H., Ledbetter, J. A., Gillespie, M. M., Lindsten, T. & Thompson, C. B. Molec. cell. Biol. 7, 4472–4481 (1987).
Gross, J. A., St. John, T. & Allison, J. P. J. Immun. 144, 3201–3210 (1990).
Gunter, K. C., Malek, T. R. & Shevach, E. M. J. exp. Med. 159, 716–730 (1984).
Gunter, K. C. et al. Nature 326, 505–507 (1987).
Jenkins, M. K. & Schwartz, R. H. J. exp. Med. 165, 302–319 (1987).
Otten, G. R. & Germain, R. N. Science 251, 1228–1231 (1991).
Jenkins, M. K., Ashwell, J. D. & Schwartz, R. H. J. Immun. 140, 3324–3330 (1988).
Linsley, P. S., Clark, E. A. & Ledbetter, J. A. Proc. natn. Acad. Sci. U.S.A. 87, 5031–5035 (1990).
Freeman, G. J. et al. J. exp. Med. 174, 625–631 (1991).
Linsley, P. S. et al. J. exp. Med. 173, 721–730 (1991).
Gimmi, C. D. et al. Proc. natn. Acad. Sci. U.S.A. 88, 6575–6579 (1991).
Jenkins, M. K., Taylor, P. S., Norton, S. D. & Urdahl, K. B. J. Immun. 147, 2461–2466 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harding, F., McArthur, J., Gross, J. et al. CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones. Nature 356, 607–609 (1992). https://doi.org/10.1038/356607a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/356607a0
This article is cited by
-
Chimeric antigen receptor T cells therapy in solid tumors
Clinical and Translational Oncology (2023)
-
Aryl hydrocarbon receptor activation ameliorates experimental colitis by modulating the tolerogenic dendritic and regulatory T cell formation
Cell & Bioscience (2022)
-
CAR-T cell potency: from structural elements to vector backbone components
Biomarker Research (2022)
-
Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
Nature Cancer (2022)
-
Long-range phasing of dynamic, tissue-specific and allele-specific regulatory elements
Nature Genetics (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.